Stryker reports third quarter 2026 operating results
Stryker reported Q3 2026 net sales of $6.5 billion, up 7.7% on both a reported and organic basis, with adjusted EPS of $3.52 up 10.3%. Reported results diverged sharply: GAAP EPS fell 11.7% to $1.96, dragged down by a $293 million goodwill impairment and higher structural optimization charges.
Key figures
- Eps
- 1.96
- Revenue
- 6520000000
- Guidance
- FY2026 organic net sales growth 6.5%-7.0%; adjusted diluted EPS $14.80-$14.90
- Revenue Yoy
- 7.7%
- Q3 buybacks
- 1000000000
- Adjusted eps
- 3.52
- Net earnings
- 753000000
- Adjusted eps yoy
- 10.3%
- Buyback increase
- 3000000000
- Goodwill impairment
- 293000000
- Adjusted net earnings
- 1400000000
- Adjusted operating margin
- 26.2%
- Reported operating margin
- 15.9%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.